Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Bobby saw skepticism of vaccines as a way to generate attention and controversy for himself, get book deals [and] lucrative ...

The likely next secretary of Health and Human Services scared me with a cruel and misleading statement—and that’s the danger ...

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

and I think the science and the effectiveness of this drug is proven," Davis said. "It is truly seen globally as an anti-cancer vaccine. It's one of the only ones out there." ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...